SecBot SecBot
144 ·Filed Sep 30, 2026

KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.
NEUTRAL
Impact 2/10
Horizondays Processed26d 14h ago SEC0001964306-26-000458
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small and routine, likely for tax or diversification purposes. Monitor for any subsequent Form 4 filings to confirm execution, but no material impact is expected.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
KMTS ▼ -4.96% at T+5d
NEUTRAL call -4.96% · α vs SPY -6.26% · entry $27.12 → $25.77
Next anchor: T+20d tomorrow
Latest observation: T+16 +4.73% FF3 residual α
Entry = T+0 close
Sep 30, 2026
via day close
T+1d
+1.16%
call +1.16% · α +0.42%
$27.43
settled 26d ago
T+5d
-4.96%
call -4.96% · α -6.26%
$25.77
settled 20d ago
T+20d
Pending
tomorrow
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Raymond W. Cohen, an officer of Kestra Medical Technologies, Ltd., filed a Form 144 on September 30, 2026, indicating intent to sell 3,330 shares of common stock with an approximate market value of $97,504. The shares were acquired via vesting of restricted stock unit awards on September 4, 2026, under the issuer's equity compensation plan. The proposed sale is small relative to the company's market cap and appears to be a routine post-vesting diversification move by an insider.

Key Facts

  • Insider Raymond W. Cohen (Officer) filed Form 144 to sell 3,330 shares of Kestra Medical Technologies common stock.
  • Estimated aggregate market value of proposed sale: $97,504.
  • Shares were acquired on September 4, 2026, via vesting of restricted stock unit awards under the issuer's equity compensation plan.
  • Broker for the proposed sale is Merrill Lynch.
  • Filing date: September 30, 2026.

Financial Impact

Proposed sale of 3,330 shares valued at approximately $97,504 — a small fraction of the company's market cap.

dilution

Risk Factors

  • Insider selling ahead of potential negative news cannot be ruled out, though the small size of the sale limits concern.
  • Form 144 is an intent to sell; the sale may not occur.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000458
Document: 0001964306-26-000458-index.html0001964306-26-000458
Document: 0001964306-26-000458.txt0001964306-26-000458
18 reports for KMTS
Performance horizon
100% Hit rate @ T+20 4 of 4 directional calls Went positive at some point 4 of 5 best @ T+20▲ +15.82%Aug 11, 2026
Filters
Rows
Reports for KMTS — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
Insider Cluster
NEUTRAL ★ 3/10
$28.76awaiting T+20—$29.42 (+2.29%)
Oct 20, 2026
6d ago
144
NEUTRAL ★ 3/10
$27.31awaiting T+20—$29.42 (+7.73%)
Oct 20, 2026
6d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$28.28awaiting T+20—$29.42 (+4.03%)
Sep 30, 2026
26d ago
144
NEUTRAL ★ 2/10
$27.12awaiting T+20—$29.42 (+8.50%)
Sep 14, 2026
6w ago
Press Release
MIXED ★ 6/10
$25.18 $26.97▲ +7.11%▲ +4.39%$29.42 (+16.84%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.85 $26.98▲ +18.07%▲ +16.21%$29.42 (+28.75%)
Sep 10, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$23.57 $25.77▲ +9.33%▲ +7.21%$29.42 (+24.82%)
Aug 31, 2026
8w ago
Press Release
NEUTRAL ★ 1/10
$25.12 $28.29▲ +12.62%▲ +12.30%$29.42 (+17.12%)
Aug 26, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$26.57 $25.76▼ −3.05%▼ −3.27%$29.42 (+10.73%)
Aug 11, 2026
10w ago
Insider Cluster
BEARISH ★ 5/10
$28.00 $23.57▲ +15.82%▲ +13.92%$29.42 (−5.07%)
Showing 10 of 18

US Market Status

Market Closed — Opens in 3h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 30, 2026